MedDataX Logo

A Study of Rofecoxib in the Treatment of Post-Operative Pain After Total Knee Joint Replacement (0966-259)

NCT ID: NCT00140920

Last Updated: 2017-05-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

PHASE4

Total Enrollment

11 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-05-25

Study Completion Date

2004-09-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A study to compare pre-operative administration of rofecoxib versus post-operative administration of diclofenac or rofecoxib, respectively, in the treatment of post-operative pain after total knee joint replacement in patients with osteoarthritis of the knee.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-220)(COMPLETED)

NCT00092365

Osteoarthritis
COMPLETED PHASE3

A Study of Two Approved Drugs in Patients With Osteoarthritis (0966-219)

NCT00092352

Osteoarthritis
COMPLETED PHASE3

A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)

NCT00140972

Osteoarthritis
COMPLETED PHASE4

A Four-Week Study Comparing Acetaminophen Extended Release and Rofecoxib in the Treatment of Osteoarthritis of the Knee

NCT00568295

Osteoarthritis of the Knee
COMPLETED PHASE3

A Study to Evaluate Rofecoxib Versus Placebo and Diclofenac in Patients With Acute Painful Rotator Cuff Syndrome

NCT00140933

Pain
TERMINATED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MK0966; rofecoxib

Intervention Type DRUG

Comparator: diclofenac 2x 75 mg

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Males or females at least 18 years of age who have osteoarthritis of the knee and have undergone total knee joint replacement.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Merck Sharp & Dohme LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Medical Monitor

Role: STUDY_DIRECTOR

Merck Sharp & Dohme LLC

Study Documents

Access uploaded study-related documents such as protocols, statistical analysis plans, or lay summaries.

Document Type: CSR Synopsis

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2005_054

Identifier Type: -

Identifier Source: secondary_id

0966-259

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)
NCT00542087 COMPLETED PHASE3
Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)
NCT00092703 COMPLETED PHASE3
Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee
NCT00689273 COMPLETED PHASE2
Parecoxib in Total Knee Arthroplasty
NCT05924412 COMPLETED PHASE4
Safety of F14 Following Total Knee Replacement
NCT04860635 SUSPENDED PHASE2/PHASE3
A Study to Assess Efficacy and Safety of the Ketoprofen vs Diclofenac
NCT04421911 COMPLETED PHASE3
A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled Arthroplasty
NCT03497039 COMPLETED PHASE1
Etoricoxib in the Treatment of Osteoarthritis (MK-0663-007)
NCT00242489 COMPLETED PHASE2
A Study to Assess the Safety and Efficacy of an Investigational Drug in Patients With Osteoarthritis (0663-071)(COMPLETED)
NCT00269191 COMPLETED PHASE3
A 2 Week Blinded Study For Pain Due To Arthritis Of The Knee
NCT00483977 TERMINATED PHASE2
A Study of the Efficacy and Safety of CF101 to Patients With Osteoarthritis of the Knee
NCT00837291 WITHDRAWN PHASE2
Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)
NCT00092742 COMPLETED PHASE3
Study to Evaluate Arthroplasty Specimens for Osteoarthritis of the Knee and Hip
NCT03949673 TERMINATED PHASE2
A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From Osteoarthritis
NCT01094262 TERMINATED PHASE2
Study of Diclofenac Capsules to Treat Osteoarthritis Pain
NCT01461369 COMPLETED PHASE3
Evaluation of Post Hospital Administration of Celecoxib Following Minimally Invasive Knee Replacement Surgery
NCT00474773 COMPLETED
A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)
NCT00157872 COMPLETED PHASE4
A Study to Evaluate the Effect of GRF6021 on Postoperative Recovery Following Primary Hip or Knee Arthroplasty
NCT03981419 COMPLETED PHASE2
Study of FX005 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
NCT01291914 COMPLETED PHASE1/PHASE2
Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip
NCT00174317 COMPLETED PHASE4
A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement
NCT05603832 COMPLETED PHASE3
Collagen-PVP vs Hylan G-F 20 in the Treatment of Knee Osteoarthritis
NCT04019782 UNKNOWN PHASE3
A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)
NCT00092781 COMPLETED PHASE3
Efficacy and Safety of Diclofenac Sodium Gel in Knee Osteoarthritis
NCT00171678 COMPLETED PHASE3
Study to Evaluate Resiniferatoxin in Patients With Knee Osteoarthritis Whose Total Knee Replacement Surgery is Delayed
NCT04386980 WITHDRAWN PHASE3